BPBT
NAVB

Boston Private Bank & Trust’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Boston Private Bank & Trust’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$74K Hold
2,313
– – ﹤0.01% 507
2014
Q4 		$87K Hold
2,313
– – ﹤0.01% 491
2014
Q3 		$61K Hold
2,313
– – ﹤0.01% 547
2014
Q2 		$68K Hold
2,313
– – ﹤0.01% 522
2014
Q1 		$86K Hold
2,313
– – ﹤0.01% 511
2013
Q4 		$96K Hold
2,313
– – ﹤0.01% 493
2013
Q3 		$123K Hold
2,313
– – 0.01% 443
2013
Q2 		$124K Buy
+2,313
New +$115K 0.01% 431

Other funds holding NAVB

PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Private Bank & Trust's NAVB Position: Q1 2015 in Review

Boston Private Bank & Trust held its Navidea Biopharmaceuticals Inc. (NAVB) position steady in Q1 2015 at 2,313 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #507.

Boston Private Bank & Trust first reported a position in NAVB in Q2 2013 and has held it in 8 quarters since. The position peaked at $124K in Q2 2013. 82 funds tracked by Wall St. Rank hold NAVB as of Q1 2015.

  • Boston Private Bank & Trust held 2,313 shares of Navidea Biopharmaceuticals Inc. worth $74K as of Q1 2015.
  • Boston Private Bank & Trust left its Navidea Biopharmaceuticals Inc. share count unchanged in Q1 2015.
  • Navidea Biopharmaceuticals Inc. made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #507 holding.
  • Boston Private Bank & Trust first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and has held it in 8 quarters since.
  • Boston Private Bank & Trust's Navidea Biopharmaceuticals Inc. position peaked at $124K in Q2 2013.
  • 82 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.